SARS-CoV-2 infection causes a decline in renal megalin expression and affects vitamin D metabolism in the kidney of K18-hACE2 mice.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 10 2024
Historique:
received: 25 01 2024
accepted: 04 10 2024
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

Patients with coronavirus disease 2019 (COVID-19) often experience acute kidney injury, linked to disease severity or mortality, along with renal tubular dysfunction and megalin loss in proximal tubules. Megalin plays a crucial role in kidney vitamin D metabolism. However, the impact of megalin loss on vitamin D metabolism during COVID-19 is unclear. This study investigated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection reduces megalin expression in proximal tubules and its subsequent effect on vitamin D metabolism in mice expressing human angiotensin converting enzyme 2 (K18-hACE2 mice). Histological and immunohistochemical staining analyses revealed glomerular and capillary congestion, and elevated renal neutrophil gelatinase-associated lipocalin levels, indicative of acute kidney injury in K18-hACE2 mice. In SARS-CoV-2-infected mice, immunohistochemical staining revealed suppressed megalin protein levels. Decreased vitamin D receptor (VDR) localization in the nucleus and increased mRNA expression of VDR, CYP27B1, and CYP24A1 were observed by quantitative PCR in SARS-CoV-2-infected mice. Serum vitamin D levels remained similar in infected and vehicle-treated mice, but an increase in tumor necrosis factor-alpha and a decrease in IL-4 mRNA expression were observed in the kidneys of the SARS-CoV-2 group. These findings suggest that megalin loss in SARS-CoV-2 infection may impact the local role of vitamin D in kidney immunomodulation, even when blood vitamin D levels remain unchanged.

Identifiants

pubmed: 39414885
doi: 10.1038/s41598-024-75338-9
pii: 10.1038/s41598-024-75338-9
doi:

Substances chimiques

Low Density Lipoprotein Receptor-Related Protein-2 0
Vitamin D 1406-16-2
Angiotensin-Converting Enzyme 2 EC 3.4.17.23
Receptors, Calcitriol 0
Lrp2 protein, mouse 0
ACE2 protein, human EC 3.4.17.23

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

24313

Subventions

Organisme : School of Allied Health Sciences, Kitasato University
ID : Grant-in-Aid for Research Project No. 2022-1020

Informations de copyright

© 2024. The Author(s).

Références

Mohamed, M. M. B. et al. Acute kidney injury associated with coronavirus disease 2019 in urban new orleans. Kidney 1, 614–622 (2020).
doi: 10.34067/KID.0002652020
Chan, L. et al. AKI in hospitalized patients with COVID-19. J. Am. Soc. Nephrol. 32, 151–160 (2021).
pubmed: 32883700 doi: 10.1681/ASN.2020050615
Robbins-Juarez, S. Y. et al. Outcomes for patients with COVID-19 and acute kidney injury: A systematic review and meta-analysis. Kidney Int Rep. 5, 1149–1160 (2020).
pubmed: 32775814 pmcid: 7314696 doi: 10.1016/j.ekir.2020.06.013
Naicker, S. et al. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 97, 824–828 (2020).
pubmed: 32204907 pmcid: 7133222 doi: 10.1016/j.kint.2020.03.001
Durvasula, R., Wellington, T., McNamara, E. & Watnick, S. COVID-19 and kidney failure in the acute care setting: Our experience from seattle. Am. J. Kidney Dis. 76, 4–6 (2020).
pubmed: 32276031 pmcid: 7141473 doi: 10.1053/j.ajkd.2020.04.001
Santoriello, D. et al. Postmortem kidney pathology findings in patients with COVID-19. J. Am. Soc. Nephrol. 31, 2158–2167 (2020).
pubmed: 32727719 pmcid: 7461662 doi: 10.1681/ASN.2020050744
Akilesh, S. et al. Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria. Am. J. Kidney Dis. 77, 82–93 (2021).
pubmed: 33045255 doi: 10.1053/j.ajkd.2020.10.001
Mohamed, M. M. B. & Velez, J. C. Q. Proteinuria in COVID-19. Clin Kidney J. 14, i40–i47 (2021).
pubmed: 33815781 pmcid: 7995522 doi: 10.1093/ckj/sfab036
Su, H. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int. 98, 219–227 (2020).
pubmed: 32327202 pmcid: 7194105 doi: 10.1016/j.kint.2020.04.003
Fisher, M. et al. AKI in hospitalized patients with and without COVID-19: A comparison study. J. Am. Soc. Nephrol. 31, 2145–2157 (2020).
pubmed: 32669322 pmcid: 7461660 doi: 10.1681/ASN.2020040509
Cheng, Y. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 97, 829–838 (2020).
pubmed: 32247631 pmcid: 7110296 doi: 10.1016/j.kint.2020.03.005
Chaudhri, I. et al. Association of proteinuria and hematuria with acute kidney injury and mortality in hospitalized patients with COVID-19. Kidney Blood Press. Res. 45, 1018–1032 (2020).
pubmed: 33171466 doi: 10.1159/000511946
Kazemi, A. et al. Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: A systematic review and meta-analysis. Adv. Nutr. 12, 1636–1658 (2021).
pubmed: 33751020 pmcid: 7989595 doi: 10.1093/advances/nmab012
Camargo, C. A. Jr. et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 127, e180-187 (2011).
pubmed: 21187313 doi: 10.1542/peds.2010-0442
Bikle, D. D. Vitamin D regulation of immune function during covid-19. Rev. Endocr. Metab. Disord. 23, 279–285 (2022).
pubmed: 35091881 pmcid: 8799423 doi: 10.1007/s11154-021-09707-4
Costagliola, G. et al. Nutraceuticals in viral infections: An overview of the immunomodulating properties. Nutrients 13, 2410 (2021).
pubmed: 34371920 pmcid: 8308811 doi: 10.3390/nu13072410
Murai, I. H. et al. Effect of a single high dose of vitamin D3 on hospital length of stay in patients with moderate to severe COVID-19: A randomized clinical trial. JAMA 325, 1053–1060 (2021).
pubmed: 33595634 doi: 10.1001/jama.2020.26848
Schuster, I. Cytochromes P450 are essential players in the vitamin D signaling system. Biochim. Biophys. Acta. 1814, 186–199 (2011).
pubmed: 20619365 doi: 10.1016/j.bbapap.2010.06.022
Holick, M. F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 80, 1678S-1688S (2004).
pubmed: 15585788 doi: 10.1093/ajcn/80.6.1678S
Yin, K. & Agrawal, D. K. Vitamin D and inflammatory diseases. J Inflamm. Res. 7, 69–87 (2014).
pubmed: 24971027 pmcid: 4070857
Holick, M. F. Vitamin D deficiency. N. Engl. J. Med. 357, 266–281 (2007).
pubmed: 17634462 doi: 10.1056/NEJMra070553
Jones, G., Prosser, D. E. & Kaufmann, M. 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin D. Arch. Biochem. Biophys. 523, 9–18 (2012).
pubmed: 22100522 doi: 10.1016/j.abb.2011.11.003
Graidis, S., Papavramidis, T. S. & Papaioannou, M. Vitamin D and acute kidney injury: A two-way causality relation and a predictive, prognostic, and therapeutic role of vitamin D. Front Nutr. 7, 630951 (2020).
pubmed: 33748167 doi: 10.3389/fnut.2020.630951
Bosworth, C. & de Boer, I. H. Impaired vitamin D metabolism in CKD. Semin. Nephrol. 33, 158–168 (2013).
pubmed: 23465502 pmcid: 3592201 doi: 10.1016/j.semnephrol.2012.12.016
Nykjaer, A. et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc. Natl. Acad. Sci. USA 98, 13895–13900 (2001).
pubmed: 11717447 pmcid: 61138 doi: 10.1073/pnas.241516998
Saito, A., Pietromonaco, S., Loo, A. K. & Farquhar, M. G. Complete cloning and sequencing of rat gp330/"megalin," a distinctive member of the low density lipoprotein receptor gene family. Proc. Natl. Acad. Sci. USA 91, 9725–9729 (1994).
pubmed: 7937880 pmcid: 44889 doi: 10.1073/pnas.91.21.9725
Hjalm, G. et al. Cloning and sequencing of human gp330, a Ca(2+)-binding receptor with potential intracellular signaling properties. Eur. J. Biochem. 239, 132–137 (1996).
pubmed: 8706697 doi: 10.1111/j.1432-1033.1996.0132u.x
Nykjaer, A. et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507–515 (1999).
pubmed: 10052453 doi: 10.1016/S0092-8674(00)80655-8
Werion, A. et al. SARS-CoV-2 causes a specific dysfunction of the kidney proximal tubule. Kidney Int. 98, 1296–1307 (2020).
pubmed: 32791255 pmcid: 7416689 doi: 10.1016/j.kint.2020.07.019
Omer, D. et al. Human kidney spheroids and monolayers provide insights into SARS-CoV-2 renal interactions. J. Am. Soc. Nephrol. 32, 2242–2254 (2021).
pubmed: 34112705 pmcid: 8729846 doi: 10.1681/ASN.2020111546
Wang, W. G., Sun, W. X., Gao, B. S., Lian, X. & Zhou, H. L. Cell cycle arrest as a therapeutic target of acute kidney injury. Curr. Protein Pept. Sci. 18, 1224–1231 (2017).
pubmed: 27634440 doi: 10.2174/1389203717666160915162238
Kellum, J. A. & Chawla, L. S. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol. Dial. Transplant. 31, 16–22 (2016).
pubmed: 26044835 doi: 10.1093/ndt/gfv130
Kilari, S., Yang, B., Sharma, A., McCall, D. L. & Misra, S. Increased transforming growth factor beta (TGF-beta) and pSMAD3 signaling in a murine model for contrast induced kidney injury. Sci. Rep. 8, 6630 (2018).
pubmed: 29700311 pmcid: 5919895 doi: 10.1038/s41598-018-24340-z
Hirsch, J. S. et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 98, 209–218 (2020).
pubmed: 32416116 pmcid: 7229463 doi: 10.1016/j.kint.2020.05.006
Chavez-Valencia, V., Orizaga-de-la-Cruz, C. & Lagunas-Rangel, F. A. Acute kidney injury in COVID-19 patients: Pathogenesis, clinical characteristics, therapy, and mortality. Diseases 10, 53 (2022).
pubmed: 35997358 pmcid: 9397016 doi: 10.3390/diseases10030053
Farkash, E. A., Wilson, A. M. & Jentzen, J. M. Ultrastructural evidence for direct renal infection with SARS-CoV-2. J. Am. Soc. Nephrol. 31, 1683–1687 (2020).
pubmed: 32371536 pmcid: 7460898 doi: 10.1681/ASN.2020040432
Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
pubmed: 32015507 pmcid: 7095418 doi: 10.1038/s41586-020-2012-7
Mizuiri, S. & Ohashi, Y. ACE and ACE2 in kidney disease. World J. Nephrol. 4, 74–82 (2015).
pubmed: 25664248 pmcid: 4317630 doi: 10.5527/wjn.v4.i1.74
George, S. et al. Evidence for SARS-CoV-2 Spike Protein in the Urine of COVID-19 Patients. Kidney 2, 924–936 (2021).
doi: 10.34067/KID.0002172021
Silva-Aguiar, R. P. et al. SARS-CoV-2 spike protein inhibits megalin-mediated albumin endocytosis in proximal tubule epithelial cells. Biochim. Biophys. Acta Mol. Basis Dis. 1868, 166496 (2022).
pubmed: 35863591 pmcid: 9290338 doi: 10.1016/j.bbadis.2022.166496
Biemesderfer, D. Regulated intramembrane proteolysis of megalin: linking urinary protein and gene regulation in proximal tubule?. Kidney Int. 69, 1717–1721 (2006).
pubmed: 16557231 doi: 10.1038/sj.ki.5000298
Li, Y., Cong, R. & Biemesderfer, D. The COOH terminus of megalin regulates gene expression in opossum kidney proximal tubule cells. Am. J. Physiol. Cell Physiol. 295, C529-537 (2008).
pubmed: 18495814 pmcid: 2518424 doi: 10.1152/ajpcell.00037.2008
Fatah, H. et al. Reduced proximal tubular expression of protein endocytic receptors in proteinuria is associated with urinary receptor shedding. Nephrol. Dial. Transplant. 33, 934–943 (2018).
pubmed: 29186471 doi: 10.1093/ndt/gfx321
Maritzen, T., Rickheit, G., Schmitt, A. & Jentsch, T. J. Kidney-specific upregulation of vitamin D3 target genes in ClC-5 KO mice. Kidney Int. 70, 79–87 (2006).
pubmed: 16672909 doi: 10.1038/sj.ki.5000445
Xu, Y. et al. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19. J. Transl. Med. 18, 322 (2020).
pubmed: 32847594 pmcid: 7447609 doi: 10.1186/s12967-020-02488-5
de Braganca, A. C. et al. Vitamin D deficiency aggravates ischemic acute kidney injury in rats. Physiol. Rep. 3, e12331 (2015).
pubmed: 25780095 pmcid: 4393165 doi: 10.14814/phy2.12331
Tourigny, A. et al. CYP24A1 exacerbated activity during diabetes contributes to kidney tubular apoptosis via caspase-3 increased expression and activation. PLoS One. 7, e48652 (2012).
pubmed: 23119081 pmcid: 3485377 doi: 10.1371/journal.pone.0048652
Wolf, M. Forging forward with 10 burning questions on FGF23 in kidney disease. J. Am. Soc. Nephrol. 21, 1427–1435 (2010).
pubmed: 20507943 doi: 10.1681/ASN.2009121293
Leaf, D. E., Wolf, M. & Stern, L. Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury. Nephrol. Dial. Transplant. 25, 1335–1337 (2010).
pubmed: 20037176 doi: 10.1093/ndt/gfp682
BaSalamah, M. A. et al. Vitamin D alleviates lead induced renal and testicular injuries by immunomodulatory and antioxidant mechanisms in rats. Sci. Rep. 8, 4853 (2018).
pubmed: 29556070 pmcid: 5859277 doi: 10.1038/s41598-018-23258-w
Mazanova, A. et al. The link between vitamin D status and NF-kappaB-associated renal dysfunction in experimental diabetes mellitus. Biochim. Biophys. Acta Gen. Subj. 1866, 130136 (2022).
pubmed: 35364123 doi: 10.1016/j.bbagen.2022.130136
Zehnder, D. et al. Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int. 74, 1343–1353 (2008).
pubmed: 18784644 pmcid: 2737358 doi: 10.1038/ki.2008.453
Rowling, M. J., Kemmis, C. M., Taffany, D. A. & Welsh, J. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J. Nutr. 136, 2754–2759 (2006).
pubmed: 17056796 doi: 10.1093/jn/136.11.2754
Baeke, F., Takiishi, T., Korf, H., Gysemans, C. & Mathieu, C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 10, 482–496 (2010).
pubmed: 20427238 doi: 10.1016/j.coph.2010.04.001
Kozai, M. et al. Thyroid hormones decrease plasma 1alpha,25-dihydroxyvitamin D levels through transcriptional repression of the renal 25-hydroxyvitamin D3 1alpha-hydroxylase gene (CYP27B1). Endocrinology 154, 609–622 (2013).
pubmed: 23307792 doi: 10.1210/en.2012-1647
Daniel, C., Sartory, N. A., Zahn, N., Radeke, H. H. & Stein, J. M. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 324, 23–33 (2008).
pubmed: 17911375 doi: 10.1124/jpet.107.127209
Sapartini, G., Wong, G. W. K., Indrati, A. R., Kartasasmita, C. B. & Setiabudiawan, B. The association between vitamin D, interleukin-4, and interleukin-10 levels and CD23+ expression with bronchial asthma in stunted children. Biomedicines 11, 2542 (2023).
pubmed: 37760982 pmcid: 10526272 doi: 10.3390/biomedicines11092542
Jin, Y. et al. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab. Invest. 93, 801–811 (2013).
pubmed: 23628901 doi: 10.1038/labinvest.2013.64
Azrielant, S. & Shoenfeld, Y. Vitamin D and the immune system. Isr. Med. Assoc. J. 19, 510–511 (2017).
pubmed: 28825771
Bowe, B., Xie, Y., Xu, E. & Al-Aly, Z. Kidney outcomes in long COVID. J. Am. Soc. Nephrol. 32, 2851–2862 (2021).
pubmed: 34470828 pmcid: 8806085 doi: 10.1681/ASN.2021060734
Curtis, L. M. Sex and gender differences in AKI. Kidney 5, 160–167 (2024).
doi: 10.34067/KID.0000000000000321
McCray, P. B. Jr. et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J. Virol. 81, 813–821 (2007).
pubmed: 17079315 doi: 10.1128/JVI.02012-06
Matsuyama, S. et al. Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells. Proc. Natl. Acad. Sci. U. S. A. 117, 7001–7003 (2020).
pubmed: 32165541 pmcid: 7132130 doi: 10.1073/pnas.2002589117
Kurosaki, Y. et al. Oxidative stress increases megalin expression in the renal proximal tubules during the normoalbuminuric stage of diabetes mellitus. Am. J. Physiol. Renal Physiol. 314, F462–F470 (2018).
pubmed: 29187367 doi: 10.1152/ajprenal.00108.2017
Kurosaki, Y. et al. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells. Mol. Cell. Biochem. 477, 689–699 (2022).
pubmed: 34973124 pmcid: 8857011 doi: 10.1007/s11010-021-04295-y

Auteurs

Yoshifumi Kurosaki (Y)

Department of Medical Laboratory Sciences, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Toshihide Matsumoto (T)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Pathology, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Takayuki Uematsu (T)

Biomedical Laboratory, Division of Biomedical Research, Kitasato University Medical Center, 6-100 Arai, Kitamoto, 364-8501, Japan.

Fumitaka Kawakami (F)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Health Administration, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Rei Kawashima (R)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Biochemistry, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Shun Tamaki (S)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Biochemistry, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Motoki Imai (M)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Molecular Diagnostics, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Takafumi Ichikawa (T)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Biochemistry, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Naohito Ishii (N)

Department of Medical Laboratory Sciences, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Hidero Kitasato (H)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.
Department of Environmental Microbiology, Kitasato University Graduate School of Medical Sciences, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan.

Hideaki Hanaki (H)

Infection Control Research Center, Ōmura Satoshi Memorial Institute, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo, 108-8641, Japan.

Makoto Kubo (M)

Regenerative Medicine and Cell Design Research Facility, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan. kuboma@kitasato-u.ac.jp.
Department of Environmental Microbiology, Kitasato University Graduate School of Medical Sciences, 1-15-1 Kitasato, Sagamihara, 252-0373, Japan. kuboma@kitasato-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH